hotspot -WSS

hotspot

author：hotspot 2025-09-28 21:54:24 - browse：894

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： US soldier in North Korean custody after crossing DMZ line

leisure time

WSS

Why you get paid to donate plasma but not blood

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

ER docs worry over extreme heat as a 'mass casualty event'

leisure time

hotspot

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

House passes resolution saying Israel isn't a 'racist or apartheid state'

What does generative AI mean for health care? We asked experts

House passes resolution saying Israel isn't a 'racist or apartheid state'

Drug repurposing or repositioning? The language matters

A strong 6.5

Guidelines to prevent youth baseball injuries need more muscle

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Sports medicine is finally prioritizing gender equality

US soldier in North Korean custody after crossing DMZ line

focus

BridgeBio heart drug succeeds in pivotal study

A Theranos scientist

US soldier in North Korean custody after crossing DMZ line

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

hotspot

leisure time

hotspot

entertainment